L-dopa
Analytical standard, >99%
- Product Code: 62054
Alias:
Levodopa; L-Dopa, L-3-(3,4-Dihydroxyphenyl)alanine, Levodopa, 3-Hydroxy-L-tyrosine
CAS:
59-92-7
| Molecular Weight: | 197.19 g./mol | Molecular Formula: | C₉H₁₁NO₄ |
|---|---|---|---|
| EC Number: | 200-445-2 | MDL Number: | MFCD00002598 |
| Melting Point: | 276-278 °C(lit.) | Boiling Point: | |
| Density: | Storage Condition: | room temperature |
Product Description:
L-dopa is primarily used in the treatment of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain. It serves as a precursor to dopamine, crossing the blood-brain barrier and being converted into dopamine to replenish depleted levels, thereby alleviating symptoms such as tremors, rigidity, and bradykinesia. Additionally, it is employed in managing conditions like restless legs syndrome and dopamine-responsive dystonia. In some cases, L-dopa is combined with carbidopa to enhance its effectiveness and reduce peripheral side effects. Its application extends to research settings for studying dopamine-related neurological functions and disorders.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to cream Crystalline powder |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.020 | 10-20 days | $24.38 |
+
-
|
L-dopa
L-dopa is primarily used in the treatment of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain. It serves as a precursor to dopamine, crossing the blood-brain barrier and being converted into dopamine to replenish depleted levels, thereby alleviating symptoms such as tremors, rigidity, and bradykinesia. Additionally, it is employed in managing conditions like restless legs syndrome and dopamine-responsive dystonia. In some cases, L-dopa is combined with carbidopa to enhance its effectiveness and reduce peripheral side effects. Its application extends to research settings for studying dopamine-related neurological functions and disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :